PARIS, France: Covaxin, the first Covid-19 vaccine developed in India, is "highly efficacious" and presents no safety concerns, according to a study published in the Lancet on Thursday.
Covaxin, developed by Bharat Biotech, gained emergency approval from the World Health Organization (WHO) last week and has already been cleared for use in 17 countries.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.